European Journal of Heart Failure

JANUARY 17, 2025

A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end-organ dysfunction.

Cardiogenic Shock 75

Cardiogenic Shock Biomarkers Pharmacology Circulation 75

Frontiers in Cardiovascular Medicine

MARCH 12, 2024

Cardiogenic shock (CS) is a time-sensitive and hemodynamically complex syndrome with a broad spectrum of etiologies and clinical presentations. Despite contemporary therapies, CS continues to maintain high morbidity and mortality ranging from 35 to 50%.

Cardiogenic Shock 145

Cardiogenic Shock Pharmacology Outcomes Research 145

JAMA Cardiology

OCTOBER 26, 2024

This substudy of the Danish-German (DanGer) Shock randomized clinical trial investigates if the use of a microaxial flow pump reduces the need for pharmacological support and what the effects are on hemodynamics and lactate clearance in patients with ST-elevation myocardial infarction–induced cardiogenic shock.

Cardiogenic Shock 102

Cardiogenic Shock Myocardial Infarction Pharmacology 102

Journal of the American Heart Association

MARCH 8, 2024

Cardiogenic shock continues to carry a high mortality rate despite contemporary care, with no breakthrough therapies shown to improve survival over the past few decades. A slowly maturing evidence base has suggested that cardiogenic shock teams may improve patient outcomes.

Cardiogenic Shock 40

Cardiogenic Shock Best Practices Outcomes Education 40

Journal of the American Heart Association

FEBRUARY 23, 2024

BackgroundThe effects of pharmacological therapy on cardiogenic shock (CS) survivors have not been extensively studied. Journal of the American Heart Association, Ahead of Print.

Cardiogenic Shock 40

Cardiogenic Shock Heart Failure Pharmacology Hospital 40

Dr. Smith's ECG Blog

NOVEMBER 19, 2016

Authors' commentary: Cardiogenic shock in the setting of severe aortic stenosis. This patient’s severe aortic stenosis (AS) and associated severe cardiogenic shock likely created the ECG pattern, resulting in a very difficult challenge for our inpatient team. If you can use Doppler, then you can diagnose it.

Ischemia 40

Ischemia Cardiogenic Shock Aortic Stenosis 40

DAIC

FEBRUARY 29, 2024

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103